Table
2:
Adverse reaction.
|
Laboratory indicators |
|
CHM |
|
No CHM |
||||||||
|
|
0 |
I |
II |
III |
IV |
|
0 |
I |
II |
III |
IV |
|
|
WBC |
|
75 |
20 |
4 |
0 |
0 |
|
68 |
12 |
11 |
0 |
0 |
|
Neutrophil* |
|
86 |
13 |
0 |
0 |
0 |
|
69 |
15 |
6 |
1 |
0 |
|
Platelets |
|
75 |
8 |
14 |
1 |
1 |
|
61 |
16 |
12 |
2 |
0 |
|
Haemoglobin |
|
85 |
10 |
2 |
2 |
0 |
|
77 |
6 |
4 |
3 |
1 |
|
Alanine transaminase (ALT) |
|
77 |
17 |
3 |
0 |
2 |
|
74 |
13 |
2 |
2 |
0 |
|
Total bilirubin (TBIL)* |
|
84 |
11 |
2 |
2 |
0 |
|
70 |
18 |
1 |
2 |
0 |
|
Urea nitrogen |
|
98 |
1 |
0 |
0 |
0 |
|
90 |
0 |
1 |
0 |
0 |
|
Creatinine |
|
98 |
1 |
0 |
0 |
0 |
|
89 |
2 |
0 |
0 |
0 |
Data are numbers of patients. *P
< 0.05, CHM group compared with the No CHM group.